Israel. July 7-8, 2016 Lecture Topics: Active Surveillance, Prostate Cancer Treatment Category: Prostate Cancer
Israel. July 7-8, 2016 Lecture Topics: Active Surveillance, Prostate Cancer Treatment Category: Prostate Cancer
Ireland. April 21-22, 2016 Lecture Topics: Smarter Prostate Cancer Screening; Prostate Cancer Treatment Category: Prostate Cancer
Sotelo R, Mora K. E, Perez L. H, Novoa J, Castillo M, Carmona O, De Andrade R, Loeb S, and Catalona WJ. “Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting From Different Assays for Free and Total Prostate-Specific Antigen (PSA).” Urology, June 2007; 69: 1143. Link: http://www.ncbi.nlm.nih.gov/pubmed/17572203
Loeb S. “Guideline of guidelines: prostate cancer screening.” BJU International 2014 September; 114: 323. PMID: 24981126. Link: http://www.ncbi.nlm.nih.gov/pubmed/23567643
Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, and Catalona WJ. “What is the true number-needed-to-screen and treat to save a life with prostate-specific antigen (PSA) testing?” Journal of Clinical Oncology January 2011; 29: 464. Link: http://www.ncbi.nlm.nih.gov/pubmed/21189374 Although number needed to screen (NNS) and number needed to treat (NNT) are useful statistics to… Read More
Schaeffer EM, Carter HB, Kettermann A, Loeb S, Ferrucci L, Landis P, Trock BJ, and Metter EJ. “Prostate Specific Antigen Testing Among the Elderly: When to Stop?” Journal of Urology, April 2009; 181: 1606. Link: http://www.ncbi.nlm.nih.gov/pubmed/19246059 Men ages 75-80 with PSA levels <3 ng/ml are unlikely to die of or experience aggressive prostate cancer… Read More
Loeb S, Carter HB, Catalona WJ, Moul JW, and Schroder FH. “Baseline Prostate-Specific Antigen Testing at a Young Age.” European Urology January 2012; 61: 1-7. PMID: 21862205. Link: http://www.ncbi.nlm.nih.gov/pubmed/21862205 This study reviews the published literature showing that baseline PSA measurements at a young age are significant predictors of later prostate cancer diagnosis and disease-specific outcomes…. Read More
Loeb S, Roehl KA, Antenor JV, Catalona WJ, Suarez BK, and Nadler RB. “Baseline Prostate Specific Antigen (PSA) Compared with Median PSA for Age Group as Predictor of Prostate Cancer Risk in Men Under 60 Years of Age” Urology, February 2006; 67: 316. Link: http://www.ncbi.nlm.nih.gov/pubmed/16442597 In the general US population, the median PSA level is… Read More
Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M, Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wooten A, Walsh PC, Costello AJ. “The Melbourne Consensus Statement on the Early Detection of Prostate Cancer.” British Journal of Urology International 2012 epub Nov 8. PMID: 24206066 Link:… Read More
Loeb S, Byrne N, Walter D, Makarov DV, Wise DR, Becker D, Giri VN. “Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation.” Cancer Treat Res Commun. 2020 Sep 28;25:100212. PMID: 33091732 Link: https://pubmed.ncbi.nlm.nih.gov/33091732/
Lynch HT, Kosoko-Lasaki O, Leslie SW, Rendell M, Shaw T, Snyder C, D’Amico AV, Buxbaum S, Isaacs WB, Loeb S, Moul JW, Powell I. “Screening for Familial and Hereditary Prostate Cancer“. International Journal of Cancer. 2015 Dec 5 epub. PMID: 26638190 Link: http://www.ncbi.nlm.nih.gov/pubmed/26638190
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ. “Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?” BJU International, November 2009; 104: 1200. Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Helfand BT, Loeb S, Kan D, Catalona WJ. “Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease.” BJU International, June 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20590552
Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, and Catalona WJ. “Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.” Journal of Urology, August 2010; 184: 501. Link: http://www.ncbi.nlm.nih.gov/pubmed/20620408
Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, and Catalona WJ. “Prostate Cancer Risk Alleles and Their Associations with Other Malignancies.” Urology October 2011; 78: 970 .e 15-20. PMID: 21820706. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190015/
Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ. “Genetic Sequence Variants are Associated with Severity of Lower Urinary Tract Symptoms and Prostate Cancer Susceptibility.” Journal of Uroloy 2012 epub November. PMID: 23159463. Link: http://www.ncbi.nlm.nih.gov/pubmed/23159463
Reinhardt D, Helfand BT, Cooper PR, Roehl KA, Catalona WJ, and Loeb S. “Prostate Cancer Risk Alleles are Associated with Prostate Cancer Tumor Volume and Prostate Size.” Journal of Urology 2013; epub Dec 14. PMID: 24345439 Link: http://www.ncbi.nlm.nih.gov/pubmed/24345439
Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT. “A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.” BJU International 2014, June epub. PMID: 24952954. Link: http://www.ncbi.nlm.nih.gov/pubmed/24952954
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA “Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?” Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390
Bostrӧm PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, and Cooperberg MR. “Genomic Predictors of Outcome in Prostate Cancer.” European Urology 2015 epub. PMID: 25913390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25913390
Loeb S, Drevin L, Robinson D, Holmberg E, Carlsson S, Lambe M, Stattin P. “Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.” Cancer Causes Control 2012; December epub. PMID: 23266834. Link: http://www.ncbi.nlm.nih.gov/pubmed/23266834 First-generation immigrants to Sweden (a high risk country for prostate cancer) have a… Read More
Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ. “Personalized PSA Testing Using Genetic Variants May Reduce Unnecessary Biopsies.” Journal of Urology 2012; epub December. PMID: 23246478. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631301/
Loeb S, Carter HB, Walsh PC, Isaacs WB, Kettermann A, Tanaka T, Ferrucci L, and Metter EJ. “Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate-Specific Antigen Level.” Journal of Urology, July 2009; 182: 101. Link: http://www.ncbi.nlm.nih.gov/pubmed/19450841 Genotype influences the risk of prostate cancer per unit increase in PSA. Prostate… Read More
Key Articles Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA “Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?” Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390 This study examined effect modification by environmental factors of the association between single nucleotide polymorphisms with… Read More
Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, Weidner W, Loeb S. “Complications After Systematic, Random, and Image-guided Prostate Biopsy.” European Urology. 2016 Aug 16 epub. PMID: 27543165. Link: https://www.ncbi.nlm.nih.gov/pubmed/27543165
Danneman D, Drevin L, Delahunt B, Samaratunga H, Robinson D, Bratt O, Loeb S, Stattin P, Egevad L. “The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012.” BJU International. 2016 Feb 25 epub. PMID:26918298. Link: http://www.ncbi.nlm.nih.gov/pubmed/26918298 Loeb S, Folkvaljon Y, Robinson D, Lissbrant IF, Egevad L, Stattin… Read More
Rochester, New York. June 8, 2016 Lecture Topic: Markers in Prostate Cancer Screening and Active Surveillance Category: Prostate Cancer
Chicago, Illinois. June 3-5, 2016 Lecture Topic: Active Surveillance for Prostate Cancer Category: Prostate Cancer
USA. May 2016 Lecture Topics: Dr Loeb gave a plenary presentation on Prostate Cancer Screening and participated on a panel with Drs Scardino, Catalona, and Hamdy. She also presented a late-breaking abstract at the plenary on Testosterone therapy and Prostate Cancer risk. Dr Loeb also gave invited lectures on Prostate Cancer at the International Prostate… Read More
Puebla, Mexico. April 14-16, 2016 Lecture Topics (Spanish): Association of PDE5 inhibitors with risk of melanoma and Prostate Cancer; Active Surveillance for Prostate Cancer Gleason grading updates for Prostate Cancer Category: Prostate Cancer, Erectile Dysfunction Medications, Men’s Health
New York. March 23, 2016 Lecture Topics: Prostate Biopsy Indications, Active Surveillance Category: Prostate Cancer
Loeb S, Walter D, Curnyn C, Gold HT, Lepor H, Makarov DV. “How Active is Active Surveillance? Intensity of Follow-Up During Active Surveillance for Prostate Cancer in the United States.” Journal of Urology 2016 Mar 2 epub. PMID: 26946161. Link: http://www.ncbi.nlm.nih.gov/pubmed/26946161
Loeb S, Folkvaljon Y, Makarov DV, Bratt O, Bill-Axelson A, Stattin P. “Five-Year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer.” Eur Urol 2014, June epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/24993868
Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. “Overdiagnosis and Overtreatment of Prostate Cancer.” European Urology 2014; epub Jan 9. PMID: 24439788 Link: http://www.ncbi.nlm.nih.gov/pubmed/24439788
Vellekoop A, Loeb S, Folkvaljon Y, Stattin P. “Population-Based Study of Predictors for Adverse Pathology Among Candidates for Active Surveillance With Gleason 6 Prostate Cancer.” Journal of Urology 2013 epub September 23. Link: http://www.ncbi.nlm.nih.gov/pubmed/24071481
Loeb S, Berglund A, Stattin P. “Population-Based Study of Utilization and Determinants of Active Surveillance and Watchful Waiting for Low- and Intermediate-Risk Prostate Cancer” Journal of Urology 2013 May 29 epub. PMID: 23727309 Link: http://www.ncbi.nlm.nih.gov/pubmed/23727309 Using nationwide Sweden data, this study showed that from 2007 to 2011, active surveillance was selected by 59% of very… Read More
O’Brien D, Loeb S, Carvalhal GF, McGuire BB, Kan D, Hofer MD, Casey JT, Helfand BT, and Catalona WJ. “Delay of Surgery in Men with Low Risk Prostate Cancer.” Journal of Urology June 2011; 185: 2143. PMID: 21496847. Link: http://www.ncbi.nlm.nih.gov/pubmed/21496847
Tosoian JJ, Loeb S, Kettermann A, Landis P, Elliot DJ, Epstein JI, Partin AW, Carter HB, and Sokoll LJ. “Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program.” Journal of Urology, February 2010; 183: 534. Link: http://www.ncbi.nlm.nih.gov/pubmed/20006883
Thaxton CS, Loeb S, Roehl KA, Kan D, and Catalona WJ. “Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Programs.” Urology, February 2010; 75: 414. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072831/
Griffin C, Yu X, Loeb S, Desireddi VN, Han M, and Catalona WJ. “Pathologic Features after Radical Prostatectomy for Potential Candidates for Active Monitoring.” Journal of Urology, September 2007; 178: 860. Link: http://www.ncbi.nlm.nih.gov/pubmed/17631347